<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments on: Nitroglycerin for the treatment of progressive prostate cancer?</title>
	<atom:link href="http://prostatecancerinfolink.net/2010/02/04/nitroglycerin-for-the-treatment-of-progressive-prostate-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://prostatecancerinfolink.net/2010/02/04/nitroglycerin-for-the-treatment-of-progressive-prostate-cancer/</link>
	<description></description>
	<lastBuildDate>Tue, 14 Feb 2012 02:28:48 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
	<item>
		<title>By: Carleton Gates</title>
		<link>http://prostatecancerinfolink.net/2010/02/04/nitroglycerin-for-the-treatment-of-progressive-prostate-cancer/#comment-7307</link>
		<dc:creator><![CDATA[Carleton Gates]]></dc:creator>
		<pubDate>Mon, 01 Mar 2010 19:52:06 +0000</pubDate>
		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=8130#comment-7307</guid>
		<description><![CDATA[It seems likely that the ethical issues can be resolved easily because the PSA velocity of prostate cancer is easily measured at either 3- or 6-monthly intervals. Thus for a trial, those who wish could enroll, and there is no need for a double-blind trial or for use of a placebo. The stabilization of PSA velocity is what matters, and the previous track record of PSA velocity is presumably known. This is the course I have personally pursued for 17 years. Selenium and Vitamin E had a minimal impact. No impact with pomegranate juice. A fatty acid synthase inhibitor (Orlistat) caused a NEGATIVE DECLINE in PSA velocity of 40% during the following 12 months. It would be most interesting to combine Orlistat with a nitro patch AND POSSIBLY Estrogel. I should add that my PSA at [diagnosis] was 9.6 ng/ml, with a Gleason of 7. Obviously there may be limitations of any treatment for patients with a Gleason score of 7 or greater.]]></description>
		<content:encoded><![CDATA[<p>It seems likely that the ethical issues can be resolved easily because the PSA velocity of prostate cancer is easily measured at either 3- or 6-monthly intervals. Thus for a trial, those who wish could enroll, and there is no need for a double-blind trial or for use of a placebo. The stabilization of PSA velocity is what matters, and the previous track record of PSA velocity is presumably known. This is the course I have personally pursued for 17 years. Selenium and Vitamin E had a minimal impact. No impact with pomegranate juice. A fatty acid synthase inhibitor (Orlistat) caused a NEGATIVE DECLINE in PSA velocity of 40% during the following 12 months. It would be most interesting to combine Orlistat with a nitro patch AND POSSIBLY Estrogel. I should add that my PSA at [diagnosis] was 9.6 ng/ml, with a Gleason of 7. Obviously there may be limitations of any treatment for patients with a Gleason score of 7 or greater.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ernest McFarlane</title>
		<link>http://prostatecancerinfolink.net/2010/02/04/nitroglycerin-for-the-treatment-of-progressive-prostate-cancer/#comment-7191</link>
		<dc:creator><![CDATA[Ernest McFarlane]]></dc:creator>
		<pubDate>Fri, 19 Feb 2010 00:39:21 +0000</pubDate>
		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=8130#comment-7191</guid>
		<description><![CDATA[What about those who refuse standard treatment on the grounds of fear of side-effects? Should they not be included in the trials also? If not, why not?]]></description>
		<content:encoded><![CDATA[<p>What about those who refuse standard treatment on the grounds of fear of side-effects? Should they not be included in the trials also? If not, why not?</p>
]]></content:encoded>
	</item>
</channel>
</rss>

